Viewing SEC Facts Units
Company Name:
MOONLAKE IMMUNOTHERAPEUTICS
CIK:
1821586
Start Filing Date:
2020-10-01
End Filing Date:
2020-10-22
ACCN:
0001213900-22-027086
Value:
$ 11,500,000
Value Error:
$ None
Created By:
Date Filed:
2022-05-16
FY:
2022
Fiscal Period:
Q1
Frame:
CY2020Q3I
Type:
us-gaap
Form:
10-Q
Units:
shares